Phibro Animal Health (PAHC) Tops Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Phibro Animal Health Corporation Reports First Quarter
November 11, 2014 4:15 PM ESTTEANECK, N.J., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its first quarter ended September 30, 2014. It also updated guidance for its fiscal year ending June 30, 2015.
Highlights for the September 2014 quarter (compared to the September 2013 quarter) Net sales of $187 million, an increase of 16% Adjusted EBITDA of $30 million, an increase of 41% Adjusted diluted EPS of $0.51 Â Â Â Â Guidance for the June 2015 fiscal year (compared to the June 2014 fiscal year) updated to reflect an increase of $4 million attributable to accelerated licensing revenue and profit for... More